Novartis Buys Dermatology Group Fougera for $1.525 Billion

May 3, 2012
The combined businesses will become the number one global company in generic dermatology medicines, with annual global sales of nearly $620 million.

In a move that Novartis (IW 1000/71) hopes will propel the company to market leader position on generic dermatology medicines, the company announed on May 3 that it will buy dermatology generics group Fougera for $1.525 billion.

Novartis said it would pay cash for the acquisition and that Fougera will be integrated into its generic pharmaceutical division.

"The combined businesses will become the number one global company in generic dermatology medicines, with estimated annual global sales of nearly $620 million, primarily in the U.S.," said the Basel-based group.

Fougera posted sales reaching $429 million in 2011 and employs about 700 people.

Copyright Agence France-Presse, 2012

See Also
Novartis Cuts 2,000 U.S. Jobs After Patent Loss

Popular Sponsored Recommendations

Food and Beverage 2024 Trends and Outlook for North America

Oct. 29, 2023
Ready to hear what 200 of your peers said are the top challenges and opportunities in 2024? Don’t fall behind. Uncover actionable insights to better prepare for 2024 in this whitepaper...

Why DataOps may be the key to unlocking the full potential of digital transformation

Nov. 3, 2023
Read the 2023 market survey conducted by IndustryWeek

How Manufacturers Can Optimize Operations with Weather Intelligence

Nov. 2, 2023
The bad news? Severe weather has emerged as one of the biggest threats to continuity and safety in manufacturing. The good news? The intelligence solutions that build weather ...

Discover How an Eye Tracking Study Improves Training Procedures

Oct. 29, 2023
Did you know that your training processes can be streamlined by visualizing and analyzing key skills within your employee base? Find out how we use eye tracking to capture advanced...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!